Search research articles
Contact Us
Filters
Showing results (261-270 of 316) with videos related to
Page
of 32
Sort By:
Archives of General Psychiatry
|
January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
Mauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders
|
April 2, 2015
An exploratory study of responses to low-dose lithium in African Americans and Hispanics
Jodi Gonzalez Arnold, Stephanie Salcedo, Terrence A Ketter, et al.
Journal of Affective Disorders
|
November 13, 2010
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression
David E Kemp, Stephen J Ganocy, Martin Brecher, et al.
Archives of General Psychiatry
|
April 4, 2007
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program
David J Miklowitz, Michael W Otto, Ellen Frank, et al.
The American Journal of Psychiatry
|
August 31, 2007
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial
David J Miklowitz, Michael W Otto, Ellen Frank, et al.
The Australian and New Zealand Journal of Psychiatry
|
April 30, 2016
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder
Ole Köhler, Louisa G Sylvia, Charles L Bowden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 17, 2020
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
The American Journal of Psychiatry
|
July 5, 2005
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial
Mauricio Tohen, Waldemar Greil, Joseph R Calabrese, et al.
Journal of Psychiatric Research
|
October 19, 2015
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR)
Michael J Ostacher, Andrew A Nierenberg, Dustin Rabideau, et al.
The Australian and New Zealand Journal of Psychiatry
|
February 15, 2022
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes
Ole Köhler-Forsberg, Louisa G Sylvia, Michael Thase, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 316) with videos related to
Sort By:
Page
of 32
Archives of General Psychiatry
|
January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
Mauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders
|
April 2, 2015
An exploratory study of responses to low-dose lithium in African Americans and Hispanics
Jodi Gonzalez Arnold, Stephanie Salcedo, Terrence A Ketter, et al.
Journal of Affective Disorders
|
November 13, 2010
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression
David E Kemp, Stephen J Ganocy, Martin Brecher, et al.
Archives of General Psychiatry
|
April 4, 2007
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program
David J Miklowitz, Michael W Otto, Ellen Frank, et al.
The American Journal of Psychiatry
|
August 31, 2007
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial
David J Miklowitz, Michael W Otto, Ellen Frank, et al.
The Australian and New Zealand Journal of Psychiatry
|
April 30, 2016
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder
Ole Köhler, Louisa G Sylvia, Charles L Bowden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 17, 2020
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
The American Journal of Psychiatry
|
July 5, 2005
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial
Mauricio Tohen, Waldemar Greil, Joseph R Calabrese, et al.
Journal of Psychiatric Research
|
October 19, 2015
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR)
Michael J Ostacher, Andrew A Nierenberg, Dustin Rabideau, et al.
The Australian and New Zealand Journal of Psychiatry
|
February 15, 2022
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes
Ole Köhler-Forsberg, Louisa G Sylvia, Michael Thase, et al.
Page
of 32